Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID H SNOW

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1639177082
CMS profile
119200
Location
DELCO, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$13,119.04

180 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID H SNOW

NPI 1639177082 · CMS profile ID 119200

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

DELCO, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1639177082?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID H SNOW, NPI 1639177082, CMS profile ID 119200. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1639177082?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). DAVID H SNOW, NPI 1639177082, CMS profile ID 119200. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1639177082?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
DAVID H SNOW, NPI 1639177082, CMS profile ID 119200, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1639177082?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

180 matching records · $13,119.04 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 180 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 180.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $16.7908/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731296213 CMS
Radius Health, Inc. $15.3108/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683932731 CMS
AbbVie, Inc. $92.8708/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079049 CMS
PFIZER INC. $11.5008/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673296903 CMS
PFIZER INC. $9.6208/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673723991 CMS
E.R. Squibb & Sons, L.L.C. $11.2108/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651422823 CMS
AbbVie, Inc. $23.1308/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079033 CMS
Janssen Biotech, Inc. $12.7708/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658725389 CMS
Novartis Pharmaceuticals Corporation $16.5708/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660013279 CMS
Amgen Inc. $20.5208/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662283489 CMS
Novartis Pharmaceuticals Corporation $12.5208/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660013275 CMS
Amgen Inc. $22.9908/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662283475 CMS
AbbVie, Inc. $20.5208/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079045 CMS
Amgen Inc. $24.7408/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662283487 CMS
Regeneron Healthcare Solutions, Inc. $91.8608/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673480119 CMS
Amgen Inc. $18.4708/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662283509 CMS
GlaxoSmithKline, LLC. $13.2508/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671210235 CMS
PFIZER INC. $13.9107/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673279073 CMS
PFIZER INC. $1.4607/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673280585 CMS
UCB, Inc. $18.0107/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688295605 CMS
Regeneron Healthcare Solutions, Inc. $1.0007/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673480115 CMS
Regeneron Healthcare Solutions, Inc. $16.6207/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673480117 CMS
Novartis Pharmaceuticals Corporation $18.9007/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660013277 CMS
Horizon Therapeutics plc $12.1407/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691501211 CMS
AbbVie, Inc. $24.3407/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079053 CMS
Amgen Inc. $23.0907/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731296215 CMS
Radius Health, Inc. $18.4307/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 683932713 CMS
UCB, Inc. $22.4707/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688295123 CMS
UCB, Inc. $0.8407/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688295125 CMS
AbbVie, Inc. $11.8207/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079043 CMS
Amgen Inc. $21.7007/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662283507 CMS
AbbVie, Inc. $1,625.0007/02/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079093 CMS
E.R. Squibb & Sons, L.L.C. $13.6207/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651422815 CMS
PFIZER INC. $9.2707/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673280381 CMS
AbbVie, Inc. $7.2906/27/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079091 CMS
AbbVie, Inc. $11.7906/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079095 CMS
PFIZER INC. $16.3106/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673280307 CMS
Horizon Therapeutics plc $11.0906/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691501207 CMS
Lilly USA, LLC $12.3006/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657768935 CMS
AbbVie, Inc. $17.2406/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079041 CMS
Amgen Inc. $18.4706/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662283503 CMS
Horizon Therapeutics plc $118.2906/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691501205 CMS
Janssen Biotech, Inc. $20.0706/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658725385 CMS
Regeneron Healthcare Solutions, Inc. $14.1806/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673480113 CMS
Novartis Pharmaceuticals Corporation $16.1106/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660013271 CMS
PFIZER INC. $13.7706/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673279889 CMS
Novartis Pharmaceuticals Corporation $19.9906/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660013267 CMS
PFIZER INC. $112.8006/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673276951 CMS
AbbVie, Inc. $23.4306/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079039 CMS
AbbVie, Inc. $1,625.0006/10/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648079087 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $13,119.04 180
PY2020 $10,073.19 129
PY2021 $4,097.18 184
PY2022 $3,567.37 190
PY2023 $3,465.63 165
PY2024 $3,118.58 129
PY2025 $5,515.11 140

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $2,103,004.64 25
PY2024 Principal investigator $333,515.16 35
PY2023 Recipient $165.16 1
PY2023 Principal investigator $296,949.77 50
PY2022 Recipient $640.00 1
PY2022 Principal investigator $117,736.88 55
PY2021 Principal investigator $124,244.42 56
PY2020 Recipient $30.60 1
PY2020 Principal investigator $139,673.94 41
PY2019 Recipient $2.75 1
PY2019 Principal investigator $216,737.73 64

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Amgen Inc. $19,275.00 12/24/2025 Non-covered Recipient Entity
INVESTIGATOR RESEARCH NETWORK LLC
A Phase 3, Multicenter, Double-blind, Randomized Controlled Study Evaluating the Efficacy and Safety of Pegloticase Administered by Subcutaneous Injection Compared With Pegloticase Administered by Intravenous Injection, Both Administered Concurrently With Methotrexate Weekly, in Participants With Uncontrolled Gout No dispute reported 06/30/2026 1246642968
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,152.37 12/17/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432488
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,000.00 11/20/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432496
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $250.00 10/17/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432493
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $250.00 10/03/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432522
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,729.50 10/02/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432509
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $6,000.00 09/03/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432530
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $4,593.74 08/14/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432542
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,000.00 08/13/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432534
Principal investigator 1 Amgen Inc. $650.21 07/28/2025 Non-covered Recipient Entity
CAPE FEAR ARTHRITIS CARE, PLLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246639899
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $5,685.41 07/11/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432518
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $116.28 07/11/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432555
Principal investigator 1 Eli Lilly and Company $13,965.00 06/16/2025 Non-covered Recipient Entity
INTERSPOND LLC
A PHASE 2B DOUBLE BLIND PLACEBO CONTROLLED STUDY TO EVALUATE PERESOLIMAB IN ADULT PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 1187883232
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $250.00 05/07/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432514
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $75.00 05/02/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432505
Principal investigator 1 Amgen Inc. $126,230.56 04/25/2025 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
A study to Evaluate the Efficacy and Safety of Dosing KRYSTEXXA (pegloticase) + MTX in Participants No dispute reported 06/30/2026 1246641067
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $7,834.54 03/17/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432526
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $9,212.40 03/14/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432501
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $107.27 03/12/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432550
Principal investigator 1 Eli Lilly and Company $333.74 03/10/2025 Non-covered Recipient Entity
INTERSPOND LLC
A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 1187882202
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $86.79 02/28/2025 Non-covered Recipient Entity
INTERSPOND LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246432546
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $475.00 02/03/2025 Non-covered Recipient Entity
INTERSPOND LLC
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) No dispute reported 06/30/2026 1246432538
Principal investigator 1 Eli Lilly and Company $8,925.00 01/22/2025 Non-covered Recipient Entity
INTERSPOND LLC
A RANDOMIZED, CONTROLLED PRAGMATIC PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 1187881258
Principal investigator 1 Eli Lilly and Company $38,100.67 01/21/2025 Non-covered Recipient Entity
INTERSPOND LLC
A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 1187884030
Principal investigator 1 Amgen Inc. $1,853,706.16 01/14/2025 Non-covered Recipient Entity
CAPE FEAR ARTHRITIS CARE, PLLC (CFA)
A study to Evaluate the Efficacy and Safety of Dosing KRYSTEXXA (pegloticase) + MTX in Participants No dispute reported 06/30/2026 1246639897